Comparing Octreotide vs Bynfezia Pen
Octreotide | Bynfezia Pen |
|
---|
Octreotide | Bynfezia Pen (octreotide) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Diarrhea, Diabetes - Type 1, Dumping Syndrome, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Postural Orthostatic Tachycardia Syndrome, Small... View more |
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Bynfezia Pen may also be used for purposes not listed in this medication guide. |
Related suggestions Carcinoid Tumor
Vasoactive Intestinal Peptide Tumor
Popular comparisons
|
|||||||
More about Octreotide | More about Bynfezia Pen (octreotide) | ||||||||
Ratings & Reviews | |||||||||
Octreotide has an average rating of 7.6 out of 10 from a total of 17 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: octreotide side effects in more detail. |
See also: Bynfezia Pen side effects in more detail. |
||||||||
Generic Availability | |||||||||
Lower cost generic |
Lower cost generic approved | ||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all octreotide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
Bynfezia Pen, Mycapssa, Sandostatin, Sandostatin LAR Depot | Other octreotide brands include: Mycapssa, Sandostatin, Sandostatin LAR Depot | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
1.5 hours |
1.5 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 155 drugs are known to interact with octreotide:
|
A total of 155 drugs are known to interact with Bynfezia Pen:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
June 26, 2020 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.